| Mouse line, construct, promoter . | Findings . | Age . | Region . | Reference . | Brain Aβ . | CAA . | Neurodegenerative and behavior changes . | Reference . |
|---|---|---|---|---|---|---|---|---|
| Tg APP models | ||||||||
| APPSw/0 (Tg2576), hAPP695, K670M/N671L, hPrP | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 7–10 mo | 9–12 mo | 6–9 mo | Hsiao et al., 1996; Domnitz et al., 2005; Kumar-Singh et al., 2005; Webster et al., 2014 |
| Loss of BBB tight junctions,a LRP1 endothelial expression, PDGFRβ+ pericytes, VSMCs | 18 mo; not studied before 18 mo | Cortex | Park et al., 2013a | |||||
| IgG perivascular deposits, loss of CD13+ pericytes, endothelial degeneration | 1, 3, 6, and 9 mo | Cortex, hippocampus | Sagare et al., 2013 | |||||
| IgG perivascular deposits, albumin perivascular deposits, microhemorrhages,b,c endothelial degeneration, pericyte degeneration, VSMC loss, swollen astrocytic end-feet | 17 and 25 mo; not studied before 17 mo | Cortex, hippocampus, thalamus | Kumar-Singh et al., 2005 | |||||
| BBB leakage of Evans blue, BBB leakage of exogenous tracers | 4 and 10 mo | Cortex | Ujiie et al., 2003 | |||||
| Loss of BBB tight junctionsa,d | 18 and 24 mo; not studied before 18 mo | Cortex, hippocampus | Biron et al., 2011 | |||||
| Loss of LRP1 endothelial expression | 4 and 6 mo | Cortex, hippocampus, thalamus | Deane et al., 2004 | |||||
| Increased RAGE vascular expression | 9 mo; not studied before 9 mo | Cortex, hippocampus | Deane et al., 2003 | |||||
| Genetically increased LRP1 expression in brain microvessels | 16 and 24 mo; not studied before 16 mo | Cortex | Bell et al., 2009 | Slowed down | Slowed down | Not studied | Bell et al., 2009 | |
| APPSw/0; Pdgfrβ+/−, accelerated loss of pericytes | IgG perivascular deposits, loss of CD13+ pericytes | 1, 3, 6, and 9 mo | Cortex, hippocampus | Sagare et al., 2013 | Accelerated, +tau pathology and loss of neurons | Accelerated | Accelerated | Sagare et al., 2013 |
| APPSw/0; Slc2a1+/−, GLUT1 endothelial haploinsufficiency | Fibrin perivascular deposits, IgG perivascular deposits, and loss of BBB tight junctions,a,d LRP1 endothelial expression, GLUT1 endothelial expression | 2 wk and 1, 8–10, 12, and 16 mo | Cortex, hippocampus | Winkler et al., 2015 | Accelerated, +loss of neurons | Not studied | Accelerated | Winkler et al., 2015 |
| APPSw/0; mdr1a/b–/–, loss of Pgp endothelial function | Loss of Pgp endothelial expression, BBB leakage of Pgp substrate, loss of LRP1 endothelial expression | 2 and 3 mo | Striatum, cortex, hippocampus | Cirrito et al., 2005 | Accelerated | Not studied | Not studied | Cirrito et al., 2005 |
| APPSw/0; Picalm+/−, PICALM endothelial haploinsufficiency | Loss of PICALM endothelial expression | 3 mo | Cortex, hippocampus | Zhao et al., 2015b | Accelerated | Accelerated | Accelerated | Zhao et al., 2015b |
| APP V717F (PDAPP), hAPP full-length, V717F, PDGFb | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 6–9 mo | 10–12 mo | 6 mo | Paul et al., 2007; Webster et al., 2014 |
| PD-hAPP, hAPP minigene, V717F/K670M/N671L, PDGFb | Blockade of RAGE | 9 mo | Cortex, hippocampus | Deane et al., 2003 | Slowed down | Not studied | Not studied | Deane et al., 2003 |
| APPSwI (TgCRND8), hAPP695, K670M/N671L/V717F, hPrP | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 3 mo | 6–7 mo | 3 mo | Domnitz et al., 2005; Webster et al., 2014 |
| Fibrin perivascular deposits | 6 mo; not studied before 6 mo | Cortex | Chen et al., 2017 | |||||
| APPSwDI, hAPP770, K670M/N671L/E693Q/D694N, mThy1 | Albumin perivascular deposits | 6 mo; not studied before 6 mo | Dorsal subiculum | Kruyer et al., 2015 | 3–6 mo | 6 mo | 3–6 mo | Davis et al., 2004; Deane et al., 2004 |
| Loss of LRP1 endothelial expression | 4 and 6 mo | Cortex, hippocampus, and thalamus | Deane et al., 2004 | |||||
| Genetically decreased LRP1 expression in brain microvessels | 16 and 24 mo; not studied before 16 mo | Cortex | Bell et al., 2009 | Accelerated | Accelerated | Not studied | Bell et al., 2009 | |
| APPSw (APP23), hAPP751, K670M/N671L, mThy1 | Microhemorrhages,b,c leukocyte infiltration | 16 and 30 mo; not studied before 16 mo | Cortex, thalamus | Beckmann et al., 2011 | 6 mo | 12 mo | 3 mo | Webster et al., 2014 |
| TetO-APPSwI, hAPP695, K670M/N671L/V717F, tetracycline-responsive promoter | Microhemorrhages,b,c increased BBB permeability to iodinated contrast agent | 14 mo; not studied before 14 mo | Cortex, hippocampus, thalamus | Tanifum et al., 2014 | 2–6 mo | 14 mo | Not studied | Tanifum et al., 2014 |
| APPSwArc (ArcAβ), hAPP695, K670M/N671L/E693G, mPrP | Microhemorrhagese and increased BBB permeability to gadolinium contrast agent | 9 and 21 mo; not studied before 9 mo | Cortex, hippocampus, olfactive bulb | Klohs et al., 2011, 2013 | 6 mo | 9–15 mo | 6 mo | Klohs et al., 2012 |
| APPSw/0; PSEN1ΔE9, m/hAPP695 K595N/M596L × hPSEN1dE9, mPrP | Microhemorrhagesb,c | 9 mo; not studied before 9 mo | Cortex | Kelly et al., 2015 | 6–7 mo | 6 mo | 6 mo | Duff et al., 1996; Webster et al., 2014 |
| Fibrin perivascular deposits | 10 mo; not studied before 10 mo | Hippocampus, periventricular zone | McManus et al., 2017 | |||||
| APPSw/0; PSEN1M146L, hAPP695 K670M/N671L × PSEN1 M146L, hPrP | Microhemorrhages,b,c albumin perivascular deposits, immunoglobulin extravasation, endothelial degeneration | 5 and 11 mo | Cortex, hippocampus, thalamus | Kumar-Singh et al., 2005 | 3–6 mo | 10 mo | 3 mo | Kumar-Singh et al., 2005 |
| APPSwFlLo; PSEN1M146L/L286V (5xFAD or Tg6799), hAPP695, K670M/N671L/I716V/V717I, mThy1, PSEN1 M146L/L286V, mThy1 | IgG perivascular deposits | 9 and 10 mo; not studied before 9 mo | Cortex | Park et al., 2017 | 2 mo | Not studied | 4–5 mo | Oakley et al., 2006; Webster et al., 2014 |
| Loss of LRP1 endothelial expression | 7 mo; not studied before 7 mo | Cortex | Storck et al., 2016 | |||||
| Loss of GLUT1 endothelial expression, increased RAGE vascular expression, increased MMP-9 vascular expression, loss of BBB tight junctionsa,d,f | 8 mo; not studied before 8 mo | Cortex | Kook et al., 2012 | |||||
| Tg PSEN1 models | ||||||||
| PSEN1−/− | Microhemorrhages,e endothelial degeneration | E18.5 | Neocortex | Wen et al., 2005 | Not studied | Not studied | Not studied (perinatal lethality) | Wen et al., 2005 |
| PSEN1M146V | Microhemorrhages,e basement membrane degeneration | 10 and 37 mo | Cortex, hippocampus | Gama Sosa et al., 2010 | 24 mo | No CAA | Not studied | Chen et al., 2000 |
| Tg tau models | ||||||||
| TetO-TauP301L (rTg4510), hMAPT P301L, tetracycline-responsive promoter | BBB leakage of Evans blue, IgG perivascular deposits, microhemorrhages,e leukocyte infiltration | 9 and 12 mo | Cortex and hippocampus | Blair et al., 2015 | No Aβ pathology; Tau pathology 12 mo | None | Not studied | Blair et al., 2015 |
| Tg pericyte-deficient models | ||||||||
| Pdgfrβ+/− | Loss of pericytes, IgG perivascular deposits, fibrin perivascular deposits, thrombin and plasmin brain extravasation, loss of BBB tight junctions,a,d brain extravasation of exogenous tracers | 1, 6, 8, 14, and 16 mo | Cortex, hippocampus | Bell et al., 2010 | Not studied | Not studied | 6–9 mo, +neurodegenerative changes, loss of neurons | Bell et al., 2010; Kisler et al., 2017b |
| PdgfrβF7/F7 | Loss of pericytes, IgG perivascular deposits, fibrin perivascular deposits, thrombin and plasmin brain extravasation, loss of BBB tight junctions,a,d brain extravasation of exogenous tracers | 6 and 8 mo; not studied before 6 mo | Cortex, hippocampus | Bell et al., 2010 | Not studied | Not studied | 6–9 mo, +neurodegenerative changes, loss of neurons | Bell et al., 2010 |
| Fibrin perivascular deposits | 1, 2, 3, 4, 8, and 12 mo | Cortex, hippocampus, striatum | Nikolakopoulou et al., 2017 |
| Mouse line, construct, promoter . | Findings . | Age . | Region . | Reference . | Brain Aβ . | CAA . | Neurodegenerative and behavior changes . | Reference . |
|---|---|---|---|---|---|---|---|---|
| Tg APP models | ||||||||
| APPSw/0 (Tg2576), hAPP695, K670M/N671L, hPrP | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 7–10 mo | 9–12 mo | 6–9 mo | Hsiao et al., 1996; Domnitz et al., 2005; Kumar-Singh et al., 2005; Webster et al., 2014 |
| Loss of BBB tight junctions,a LRP1 endothelial expression, PDGFRβ+ pericytes, VSMCs | 18 mo; not studied before 18 mo | Cortex | Park et al., 2013a | |||||
| IgG perivascular deposits, loss of CD13+ pericytes, endothelial degeneration | 1, 3, 6, and 9 mo | Cortex, hippocampus | Sagare et al., 2013 | |||||
| IgG perivascular deposits, albumin perivascular deposits, microhemorrhages,b,c endothelial degeneration, pericyte degeneration, VSMC loss, swollen astrocytic end-feet | 17 and 25 mo; not studied before 17 mo | Cortex, hippocampus, thalamus | Kumar-Singh et al., 2005 | |||||
| BBB leakage of Evans blue, BBB leakage of exogenous tracers | 4 and 10 mo | Cortex | Ujiie et al., 2003 | |||||
| Loss of BBB tight junctionsa,d | 18 and 24 mo; not studied before 18 mo | Cortex, hippocampus | Biron et al., 2011 | |||||
| Loss of LRP1 endothelial expression | 4 and 6 mo | Cortex, hippocampus, thalamus | Deane et al., 2004 | |||||
| Increased RAGE vascular expression | 9 mo; not studied before 9 mo | Cortex, hippocampus | Deane et al., 2003 | |||||
| Genetically increased LRP1 expression in brain microvessels | 16 and 24 mo; not studied before 16 mo | Cortex | Bell et al., 2009 | Slowed down | Slowed down | Not studied | Bell et al., 2009 | |
| APPSw/0; Pdgfrβ+/−, accelerated loss of pericytes | IgG perivascular deposits, loss of CD13+ pericytes | 1, 3, 6, and 9 mo | Cortex, hippocampus | Sagare et al., 2013 | Accelerated, +tau pathology and loss of neurons | Accelerated | Accelerated | Sagare et al., 2013 |
| APPSw/0; Slc2a1+/−, GLUT1 endothelial haploinsufficiency | Fibrin perivascular deposits, IgG perivascular deposits, and loss of BBB tight junctions,a,d LRP1 endothelial expression, GLUT1 endothelial expression | 2 wk and 1, 8–10, 12, and 16 mo | Cortex, hippocampus | Winkler et al., 2015 | Accelerated, +loss of neurons | Not studied | Accelerated | Winkler et al., 2015 |
| APPSw/0; mdr1a/b–/–, loss of Pgp endothelial function | Loss of Pgp endothelial expression, BBB leakage of Pgp substrate, loss of LRP1 endothelial expression | 2 and 3 mo | Striatum, cortex, hippocampus | Cirrito et al., 2005 | Accelerated | Not studied | Not studied | Cirrito et al., 2005 |
| APPSw/0; Picalm+/−, PICALM endothelial haploinsufficiency | Loss of PICALM endothelial expression | 3 mo | Cortex, hippocampus | Zhao et al., 2015b | Accelerated | Accelerated | Accelerated | Zhao et al., 2015b |
| APP V717F (PDAPP), hAPP full-length, V717F, PDGFb | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 6–9 mo | 10–12 mo | 6 mo | Paul et al., 2007; Webster et al., 2014 |
| PD-hAPP, hAPP minigene, V717F/K670M/N671L, PDGFb | Blockade of RAGE | 9 mo | Cortex, hippocampus | Deane et al., 2003 | Slowed down | Not studied | Not studied | Deane et al., 2003 |
| APPSwI (TgCRND8), hAPP695, K670M/N671L/V717F, hPrP | Fibrin perivascular deposits, BBB leakage of Evans blue | 6 and 12 mo; not studied before 6 mo | Cortex, hippocampus | Paul et al., 2007 | 3 mo | 6–7 mo | 3 mo | Domnitz et al., 2005; Webster et al., 2014 |
| Fibrin perivascular deposits | 6 mo; not studied before 6 mo | Cortex | Chen et al., 2017 | |||||
| APPSwDI, hAPP770, K670M/N671L/E693Q/D694N, mThy1 | Albumin perivascular deposits | 6 mo; not studied before 6 mo | Dorsal subiculum | Kruyer et al., 2015 | 3–6 mo | 6 mo | 3–6 mo | Davis et al., 2004; Deane et al., 2004 |
| Loss of LRP1 endothelial expression | 4 and 6 mo | Cortex, hippocampus, and thalamus | Deane et al., 2004 | |||||
| Genetically decreased LRP1 expression in brain microvessels | 16 and 24 mo; not studied before 16 mo | Cortex | Bell et al., 2009 | Accelerated | Accelerated | Not studied | Bell et al., 2009 | |
| APPSw (APP23), hAPP751, K670M/N671L, mThy1 | Microhemorrhages,b,c leukocyte infiltration | 16 and 30 mo; not studied before 16 mo | Cortex, thalamus | Beckmann et al., 2011 | 6 mo | 12 mo | 3 mo | Webster et al., 2014 |
| TetO-APPSwI, hAPP695, K670M/N671L/V717F, tetracycline-responsive promoter | Microhemorrhages,b,c increased BBB permeability to iodinated contrast agent | 14 mo; not studied before 14 mo | Cortex, hippocampus, thalamus | Tanifum et al., 2014 | 2–6 mo | 14 mo | Not studied | Tanifum et al., 2014 |
| APPSwArc (ArcAβ), hAPP695, K670M/N671L/E693G, mPrP | Microhemorrhagese and increased BBB permeability to gadolinium contrast agent | 9 and 21 mo; not studied before 9 mo | Cortex, hippocampus, olfactive bulb | Klohs et al., 2011, 2013 | 6 mo | 9–15 mo | 6 mo | Klohs et al., 2012 |
| APPSw/0; PSEN1ΔE9, m/hAPP695 K595N/M596L × hPSEN1dE9, mPrP | Microhemorrhagesb,c | 9 mo; not studied before 9 mo | Cortex | Kelly et al., 2015 | 6–7 mo | 6 mo | 6 mo | Duff et al., 1996; Webster et al., 2014 |
| Fibrin perivascular deposits | 10 mo; not studied before 10 mo | Hippocampus, periventricular zone | McManus et al., 2017 | |||||
| APPSw/0; PSEN1M146L, hAPP695 K670M/N671L × PSEN1 M146L, hPrP | Microhemorrhages,b,c albumin perivascular deposits, immunoglobulin extravasation, endothelial degeneration | 5 and 11 mo | Cortex, hippocampus, thalamus | Kumar-Singh et al., 2005 | 3–6 mo | 10 mo | 3 mo | Kumar-Singh et al., 2005 |
| APPSwFlLo; PSEN1M146L/L286V (5xFAD or Tg6799), hAPP695, K670M/N671L/I716V/V717I, mThy1, PSEN1 M146L/L286V, mThy1 | IgG perivascular deposits | 9 and 10 mo; not studied before 9 mo | Cortex | Park et al., 2017 | 2 mo | Not studied | 4–5 mo | Oakley et al., 2006; Webster et al., 2014 |
| Loss of LRP1 endothelial expression | 7 mo; not studied before 7 mo | Cortex | Storck et al., 2016 | |||||
| Loss of GLUT1 endothelial expression, increased RAGE vascular expression, increased MMP-9 vascular expression, loss of BBB tight junctionsa,d,f | 8 mo; not studied before 8 mo | Cortex | Kook et al., 2012 | |||||
| Tg PSEN1 models | ||||||||
| PSEN1−/− | Microhemorrhages,e endothelial degeneration | E18.5 | Neocortex | Wen et al., 2005 | Not studied | Not studied | Not studied (perinatal lethality) | Wen et al., 2005 |
| PSEN1M146V | Microhemorrhages,e basement membrane degeneration | 10 and 37 mo | Cortex, hippocampus | Gama Sosa et al., 2010 | 24 mo | No CAA | Not studied | Chen et al., 2000 |
| Tg tau models | ||||||||
| TetO-TauP301L (rTg4510), hMAPT P301L, tetracycline-responsive promoter | BBB leakage of Evans blue, IgG perivascular deposits, microhemorrhages,e leukocyte infiltration | 9 and 12 mo | Cortex and hippocampus | Blair et al., 2015 | No Aβ pathology; Tau pathology 12 mo | None | Not studied | Blair et al., 2015 |
| Tg pericyte-deficient models | ||||||||
| Pdgfrβ+/− | Loss of pericytes, IgG perivascular deposits, fibrin perivascular deposits, thrombin and plasmin brain extravasation, loss of BBB tight junctions,a,d brain extravasation of exogenous tracers | 1, 6, 8, 14, and 16 mo | Cortex, hippocampus | Bell et al., 2010 | Not studied | Not studied | 6–9 mo, +neurodegenerative changes, loss of neurons | Bell et al., 2010; Kisler et al., 2017b |
| PdgfrβF7/F7 | Loss of pericytes, IgG perivascular deposits, fibrin perivascular deposits, thrombin and plasmin brain extravasation, loss of BBB tight junctions,a,d brain extravasation of exogenous tracers | 6 and 8 mo; not studied before 6 mo | Cortex, hippocampus | Bell et al., 2010 | Not studied | Not studied | 6–9 mo, +neurodegenerative changes, loss of neurons | Bell et al., 2010 |
| Fibrin perivascular deposits | 1, 2, 3, 4, 8, and 12 mo | Cortex, hippocampus, striatum | Nikolakopoulou et al., 2017 |
APP, amyloid precursor protein; CAA, cerebral amyloid angiopathy; GLUT1, glucose transporter 1; hPrP, hamster prion promoter; IgG, immunoglobulin G; LRP1, low-density lipoprotein receptor-related protein 1; MAPT, microtubule-associated protein tau; MMP-9, matrix metalloproteinase-9; mPrP, mouse prion promoter; mThy1, mouse thymus cell antigen 1 promoter; PDGFRβ, platelet-derived growth factor receptor β; Pgp, P-glycoprotein; PICALM, phosphatidylinositol binding clathrin assembly protein; PSEN1, presenilin 1; RAGE, receptor for advanced glycation end products; VSMC, vascular smooth muscle cell.
Loss of BBB tight junctions as shown by high-resolution confocal microscopy analysis.
Microhemorrhages (hemosiderin deposits) at the capillary level.
Microhemorrhages (hemosiderin deposits) at the arteriolar level.
Loss of BBB tight junctions as shown by immunoblotting of isolated brain capillaries.
The exact vascular location is difficult to determine.
Loss of BBB tight junctions as shown by electron microscopy analysis.